Literature DB >> 36080509

Correction: Wang et al. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma. Molecules 2019, 24, 3540.

Xi Wang1, Yarong Zhao1, Shiyan Dong1, Robert J Lee2, Dongsheng Yang3, Huan Zhang1, Lesheng Teng1.   

Abstract

When reviewing our publications, an error in article [...].

Entities:  

Year:  2022        PMID: 36080509      PMCID: PMC9457558          DOI: 10.3390/molecules27175729

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.927


When reviewing our publications, an error in article [1] caught our attention. The H&E-stained image of the lung for the Tf-LPs treatment (Figure 9) incorrectly used the picture of the lung treated with the control. Here, we provide the corrected Figure 9 below. The data were re-analyzed, and there is no change to the conclusion of the study.
Figure 9

Histological analysis of mice treated with Tf-LPs. Tf-LPs groups showed that no abnormality in these organs were provided, suggesting the safety of Tf-LPs. Abbreviations: LPs, DOX-loaded liposomes; Tf-LPs, DOX-loaded Tf-liposomes.

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
  1 in total

1.  Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma.

Authors:  Xi Wang; Yarong Zhao; Shiyan Dong; Robert J Lee; Dongsheng Yang; Huan Zhang; Lesheng Teng
Journal:  Molecules       Date:  2019-09-30       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.